PMID: 9537277Apr 16, 1998Paper

The cost of treating paediatric malaria admissions and the potential impact of insecticide-treated mosquito nets on hospital expenditure

Tropical Medicine & International Health : TM & IH
J M KirigiaA Mills

Abstract

To calculate the costs at Kilifi District Hospital (KDH) and Malindi Sub-district Hospital (MSH) of treating paediatric malaria admissions including three common presentations of severe paediatric malaria, i.e. cerebral malaria, severe malaria anaemia and malaria-associated seizures; and to estimate the implications for hospital expenditure of a reduction in paediatric malaria admissions. Patient data were obtained from hospital records. All costs were allocated to departments that provided direct patient care by a four-stage step-down procedure. Laboratory and drug costs of treating paediatric malaria admissions were separately identified. Unit recurrent costs per admission in KDH ranged from US $57 for 'other' paediatric malaria to US $105 for cerebral malaria, and in MSH from US $33 to US $44 for the same categories. The annual recurrent cost of treating all paediatric malaria admissions to KDH prior to the trial was estimated at US $78 900. Adjusting for preintervention differences in malaria admission rates and age between intervention and control areas, the ITBN trial found a 41% reduction in paediatric malaria admissions. The reduction in admissions resulted in an estimated saving of US $6240 in the cost of treating paed...Continue Reading

References

May 25, 1995·The New England Journal of Medicine·K MarshN Peshu
Jul 1, 1993·Transactions of the Royal Society of Tropical Medicine and Hygiene·R W SnowC Newbold
Apr 1, 1996·Tropical Medicine & International Health : TM & IH·C G NevillR W Snow
Apr 29, 2008·Journal of the American Mosquito Control Association·Joseph M MwangangiRobert J Novak

❮ Previous
Next ❯

Citations

May 24, 2007·JAMA : the Journal of the American Medical Association·Richard IdroCharles Newton
Mar 1, 2005·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·G L S CouitchéréJ Andoh
May 18, 1999·Transactions of the Royal Society of Tropical Medicine and Hygiene·R W SnowJ Ouma
Dec 7, 2002·Health Policy·Reginald Ikechukwu ChimaAnne Mills
Aug 2, 2003·Annals of General Hospital Psychiatry·Joses M Kirigia, Luis G Sambo
Jul 20, 2012·PharmacoEconomics·Paul GavazaStar Khoza
Nov 13, 2013·The American Journal of Tropical Medicine and Hygiene·Alison B ComfortPhilip E Thuma
Mar 13, 2003·Tropical Medicine & International Health : TM & IH·Charles Hongoro, Barbara McPake
Nov 19, 2008·Cost Effectiveness and Resource Allocation : C/E·Taghreed AdamDavid B Evans
Jul 28, 2004·Health Policy·Janet Dzator, John Asafu-Adjaye

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.